dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

CT Homepage

Siemens focuses on digitalization at HIMSS Its expanded digital service portfolio will be on display

Canon adds radiation oncology functioning to Aquilion CTs Can be shared between radiology and radiation oncology departments

Fujifilm to unveil latest version of Synapse 3D platform at HIMSS Five new capabilities for advanced visualization

Philips and MIM Software collab to streamline radiotherapy treatment planning Integrate portfolios of CT, MR and software solutions

Canon Medical debuts Aqilion Start CT system at Arab Health Designed for areas that lack access to diagnostic CT scanners

Dennis Durmis MITA names chair of board of directors

Dr. Michael W. Penney Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine appoints vice chair for community radiology

FDA gives nod to new clearance for iSchemaView’s RAPID platform Can help select which stroke patients require clot removal procedures

Capitol acquires network of radiology clinics in Australia Offer CT, MR, mammography, ultrasound and OPG services

Belgium hospital implements Aidoc's AI neuro solution Integrated into GE PACS without changes to workflow

Progenics offers Curium exclusive license
to distribute its imaging agent, PyL

Progenics Pharmaceuticals selects Curium as European distributor of PyL

by John R. Fischer , Staff Reporter
Progenics Pharmaceuticals has selected Curium to be the distributor of its PSMA-targeted small molecule PET/CT imaging agent, PyL, in Europe.

The oncology company has granted an exclusive license to Curium to develop, and oversee regulatory approval and commercialization of the tracer, which is currently in Phase 3 development and designed to visualize prostate cancer.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



“Curium is a world-class leader in nuclear medicine and an ideal partner for PyL, with the infrastructure, commercial footprint and experience in prostate cancer to position PyL for success in Europe,” Mark Baker, CEO of Progenics, said in a statement. “This collaboration accelerates development of PyL in this important market, while we focus our internal efforts on advancing our Phase 3 CONDOR trial and laying the groundwork for commercialization in the United States.”

A nuclear medicine manufacturer, Curium recently partnered with RadioMedix to develop and commercialize 64Cu-Dotatate, a tracer with a 12-hour half-life that can be used to identify suspected neuroendocrine tumors during PET exams.

It also expanded its European footprint to 25 sites back in May with the acquisition of PET diagnostics maker, Cyclopharma. The move expanded its French network to 13 radiopharmacies.

The addition of the distribution rights for PyL to the Curium portfolio is a classic example of its initiative to continue growing and expanding its portfolio of nuclear medicine diagnostics, according to Curium CEO Renaud Dehareng.

“PyL has the potential to detect small lesions, offering significant advantages over existing products and others in development,” he said. “We look forward to leveraging our success with F-Choline in prostate cancer to advance the development and commercial uptake of this next-generation product.”

Curium is set to meet with European regulators in the first half of 2019 to determine an agreed-upon regulatory path.

Progenics is entitled to royalties on net sales.

CT Homepage


You Must Be Logged In To Post A Comment

Werben
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED